Your browser doesn't support javascript.
loading
Transient receptor potential cation channel subfamily V member 1 (TRPV1) targeted PET imaging.
Tateishi, Ukihide; Doi, Hisashi.
Afiliação
  • Tateishi U; Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University Graduate School of Medicine, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
  • Doi H; Research Institute for Drug Discovery Science, Collaborative Creation Research Center, Organization for Research Promotion, Osaka Metropolitan University, 1-1 Gakuencho, Naka-ku, Sakai, Osaka, 599-8531, Japan.
Jpn J Clin Oncol ; 54(4): 386-394, 2024 Apr 06.
Article em En | MEDLINE | ID: mdl-38251773
ABSTRACT
Transient receptor potential cation channel subfamily V member 1 (TRPV1) was identified using capsaicin, a pungent compound that is present in red pepper. The activation of TRPV1 induces an influx of calcium ions into cells and causes excitation of sensory neurons, associating with thermal sensing, sweating and pain. TRPV1 is also identified in various types of cancer cells. The expression of TRPV1 in cancer cells depends on the type of cancer and the stage of the disease. Therefore, TRPV1 has been considered a potential target of medicinal chemistry for drug development, and blocking its activation may lead to cancer therapy and pain relief. However, the details of the pathophysiological function of TRPV1 in vivo are still unclear. To explore practical use of TRPV1, we focused on positron emission tomography imaging and developed a 11C-radiolabeled tracer to visualize TRPV1.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tomografia por Emissão de Pósitrons / Canais de Cátion TRPV Limite: Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tomografia por Emissão de Pósitrons / Canais de Cátion TRPV Limite: Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão